Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

CTM BioTech Company Profile

06:56 EDT 20th April 2014 | BioPortfolio

CTM BioTech offers bio-pharmaceutical companies and research organisations a range of contract services from early stage process development and pre-clinical production through, where required, to later stage project management services.The aim of CTM is to bridge the gap that exists between the clients' in-house, research-phase of development and large-scale GMP production, by working in collaboration with laboratories to enable their products to get to the clinic in a timely, cost efficient manner.
CTM has been designed to meet your organisation's bio-pharmaceutical needs in an innovative way by offering the following range of services:


Babraham Research Campus Babraham Hall
United Kingdom


Phone: 44 (0)1223 496 070
Fax: 44 (0)1223 496 061

News Articles [747 Associated News Articles listed on BioPortfolio]

BB Biotech: Biotech-Sektor weiterhin positiv - Aktiennews

Schaffhausen - Der Nasdaq Biotech Index legte im 4. Quartal nochmals um 8.3% (in USD) zu, sodass 2013 zu einem der besten Biotech-Jahre avancierte, so die BB Biotech AG (ISIN: CH0038389992, WKN: A0...

The Entrepreneurial Diaspora Enabled By Biotech M&A

The recycling of equity capital through realized returns is a critically important element of biotech investing.  When public biotech companies get bought, like Genentech by Roche, or smaller deals l...

The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List

We’ve heard a lot this year about the IPO boom for biotech companies. Even after a few high-profile blowups (Ariad, Sarepta), the public biotech stock indexes are still outperforming the Nasdaq Comp...

NH Lawmakers Explain Why They Voted Against Biotech Labeling Bill

Members of the New Hampshire (NH) Environment and Agriculture Committee namely Rep. Tara Sad and Rep. Bob Haefner explained why they voted against House Bill 660, which requires labeling of biotech fo...

Russia to Allow Biotech Crop Cultivation in 2014

Russia will be allowed to cultivate biotech crops in 2014, according to government decree no. 839. The decision will be implemented starting July 1, 2014. However, the registration of commercial biote...

2013 Pharma and Biotech Financial Report

Big Pharma and biotech continue to need each other. But biotech is feeling slightly more confident as the options for IPOs get better, writes Peter Young.

2013′s Untold Biotech Story: Success Of The 2011-12 IPO Class

The past year has certainly been the most exciting one for Biotech IPOs since 2000, with dozens of new offerings and compelling therapeutic narratives.  But focusing on these new IPOs misses an equal...

Biotech Meds Are Swelling Those Pharma Pipelines

Small molecule discovery is clearly taking a back seat to biotech products, thanks to new technologies and higher pricing. A new analysis finds that biotech products accounted for 71 percent of the 10...

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Biotech methods and advances.

Cover illustration: Our latest Biotech Methods & Advances special issue is edited by our Editors-in-Chief Prof. Alois Jungbauer and Prof. Sang Yup Lee. As always, the special issue is a collection of...

Editorial: Latest methods and advances in biotechnology.

The latest "Biotech Methods and Advances" special issue of Biotechnology Journal continues the BTJ tradition of featuring the latest breakthroughs in biotechnology. The special issue is edited by our...

What's fueling the biotech engine-2012 to 2013.

Biotech patents and science policy: the Spanish experience.

The p53-MDM2/MDMX axis - A chemotype perspective.

The protein-protein interaction (PPI) of the tumor suppressor p53 and its negative regulator MDM2 consists of the most intense studied PPI with a group of small molecular weight antagonists described...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...

Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial

This is a randomized, controlled trial in liver transplantation in which conventional immunosuppressive treatment will be compared with a therapeutic strategy consisting in pre-transplant...

Companies [808 Associated Companies listed on BioPortfolio]

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

Cella Biotech

Cella Biotech is a company that is specialized in confirming and mapping protein-protein interactions using the yeast two-hybrid system. Companies and institutions can outsource some of their protein-...

Ani Biotech Oy

Ani Biotech Oy is a Finnish biotechnology company developing, manufacturing and selling diagnostic rapid tests for laboratory, physician office and home use. Ani Biotech is now providing new optional...

More Information about "CTM BioTech" on BioPortfolio

We have published hundreds of CTM BioTech news stories on BioPortfolio along with dozens of CTM BioTech Clinical Trials and PubMed Articles about CTM BioTech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CTM BioTech Companies in our database. You can also find out about relevant CTM BioTech Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record